LLY

905.88

-0.07%↓

UNH

580.35

+0.42%↑

NVO

132.1

+0.1%↑

JNJ

166.33

-0.59%↓

ABBV

192.96

-0.17%↓

LLY

905.88

-0.07%↓

UNH

580.35

+0.42%↑

NVO

132.1

+0.1%↑

JNJ

166.33

-0.59%↓

ABBV

192.96

-0.17%↓

LLY

905.88

-0.07%↓

UNH

580.35

+0.42%↑

NVO

132.1

+0.1%↑

JNJ

166.33

-0.59%↓

ABBV

192.96

-0.17%↓

LLY

905.88

-0.07%↓

UNH

580.35

+0.42%↑

NVO

132.1

+0.1%↑

JNJ

166.33

-0.59%↓

ABBV

192.96

-0.17%↓

LLY

905.88

-0.07%↓

UNH

580.35

+0.42%↑

NVO

132.1

+0.1%↑

JNJ

166.33

-0.59%↓

ABBV

192.96

-0.17%↓

Search

AcelRx Pharmaceuticals Inc

Closed

0

Overview

Share price change

24h

Current

Min

Max

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+532.91 upside

AcelRx Pharmaceuticals Inc Chart

Past performance is not a reliable indicator of future results.

Related News

18 Sept 2024, 23:48 UTC

Top News

Republican Divisions Sink House Bill as Government Shutdown Nears -- Update

18 Sept 2024, 22:50 UTC

Top News

Republican Divisions Sink House Bill as Government Shutdown Nears -- WSJ

18 Sept 2024, 22:46 UTC

Top News

Boeing Furloughs White-Collar Workers as Strike Worsens Cash Crunch -- 2nd Update

18 Sept 2024, 22:03 UTC

Top News

Fed Cuts Rates by Half Percentage Point -- 6th Update -2-

18 Sept 2024, 22:03 UTC

Top News

Fed Cuts Rates by Half Percentage Point -- 6th Update

18 Sept 2024, 21:59 UTC

Top News

AT&T Will Remove Lead Cables From Lake Tahoe -- WSJ

18 Sept 2024, 21:44 UTC

Top News

GameStop CEO Cohen to Pay Nearly $1M for Alleged Wells Fargo Securities-Acquisition Violation -- Update

18 Sept 2024, 21:02 UTC

Market Talk

Global Equities Roundup: Market Talk

18 Sept 2024, 21:02 UTC

Market Talk

T-Mobile Capital Plan Keeps Its Options Open -- Market Talk

18 Sept 2024, 20:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

18 Sept 2024, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

18 Sept 2024, 20:33 UTC

Top News

Stocks Slip After Fed Cuts Rates -- WSJ

18 Sept 2024, 20:14 UTC

Market Talk

Bank of Canada Minutes Reveal Consideration of Faster Rate-Cutting Cycle -- Market Talk

18 Sept 2024, 20:07 UTC

Top News

U.S. Stocks Pull Back After Fed Rate Cut -- WSJ

18 Sept 2024, 19:27 UTC

Top News

T-Mobile Strikes Deal With OpenAI -- Update

18 Sept 2024, 19:27 UTC

Market Talk

Fed's 50-Basis-Point Cut Looks To Be Pre-Emptive -- Market Talk

18 Sept 2024, 19:22 UTC

Market Talk

Crude Oil Gets Little Help From Fed Rate Cut -- Market Talk

18 Sept 2024, 19:12 UTC

Top News

Why the Bank of England Won't Follow the Fed -- Barrons.com

18 Sept 2024, 19:10 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18 Sept 2024, 19:10 UTC

Market Talk

Powell Shows Confidence Inflation Can Cool Without Much Jobs Loss -- Market Talk

18 Sept 2024, 19:07 UTC

Market Talk

Fed's Rate Cut To Help Emerging Market Central Banks Carry On Easing -- Market Talk

18 Sept 2024, 19:02 UTC

Market Talk

U.S. Natural Gas Futures Fall Ahead of Storage Report -- Market Talk

18 Sept 2024, 19:01 UTC

Market Talk

Fed's 50Bp Rate Cut Should Alleviate Fears Of It Being Behind Curve -- Market Talk

18 Sept 2024, 18:56 UTC

Market Talk

Treasury Yields Recover As Powell Talks About Deep Fed Cut -- Market Talk

18 Sept 2024, 18:55 UTC

Top News

U.S. Stocks Rise After Fed Rate Reduction -- WSJ

18 Sept 2024, 18:52 UTC

Market Talk

Fed Rate Cut Gives Bank of Mexico Room to Step Up Easing -- Market Talk

18 Sept 2024, 18:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18 Sept 2024, 18:46 UTC

Market Talk

Path Of Fed Cuts Expected To Be Moderate -- Market Talk

18 Sept 2024, 18:32 UTC

Top News

Fed Cuts Rates by Half Percentage Point -- 5th Update

18 Sept 2024, 18:30 UTC

Market Talk

Markets Reaction to Rate Cut to Be Determined by Fedspeak -- Market Talk

Peer Comparison

Price change

AcelRx Pharmaceuticals Inc Forecast

Price Target

By TipRanks

532.91% upside

12 Months Forecast

Average 5 USD  532.91%

High 5 USD

Low 5 USD

Based on 1 Wall Street analysts offering 12 month price targets forAcelRx Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell